Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome

The Journal of Clinical Endocrinology and Metabolism
Sho-Ichi YamagishiTsutomu Imaizumi

Abstract

Pigment epithelium-derived factor (PEDF), a potent inhibitor of angiogenesis with neuronal differentiating activity, inhibits endothelial cell injury in vitro, thus suggesting the involvement of PEDF in atherosclerosis. Therefore, elucidating the relationship between serum levels of PEDF and coronary risk factors could provide a clue to understanding the pathophysiological role of PEDF in vivo. We examined whether serum levels of PEDF were associated with risk factors for coronary artery disease. The study was designed as a cross-sectional study. The study was set within the general community. A total of 196 general Japanese residents (age 65.7 +/- 9.3 yr; 71 males and 125 females) without clinical evidence of coronary or peripheral arterial occlusive diseases were enrolled in this study. PEDF showed a normal distribution, ranging from 8-24 microg/ml, with a mean of 14.6 +/- 3.2 microg/ml. Multivariate analyses revealed that uric acid (P < 0.001), waist circumference (P = 0.009), insulin (P = 0.019), and triglycerides (P = 0.028) were significant independent determinants of serum PEDF levels. Age- and uric acid-adjusted PEDF levels were significantly higher (P = 0.048 for men and P = 0.007 for women) in proportion to the accumu...Continue Reading

Citations

Jul 28, 2013·The International Journal of Biochemistry & Cell Biology·Zhiyu DaiGuoquan Gao
Oct 13, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S FamullaJ Eckel
Jan 16, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J M Moreno-NavarreteJ M Fernández-Real
Dec 2, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Toshiko FujimuraSeiya Okuda
Jan 19, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Eliza Moskowitz-KassaiMichael S Goligorsky
Jan 19, 2007·International Journal of Clinical Practice·S-I YamagishiT Imaizumi
Sep 16, 2006·The British Journal of Ophthalmology·Yumiko YoshidaRyoji Yamakawa
Oct 8, 2009·American Journal of Physiology. Endocrinology and Metabolism·Min WangSarah X Zhang
Aug 30, 2012·The Journal of Clinical Endocrinology and Metabolism·Kyle L SunderlandKevin R Short
Dec 15, 2010·PloS One·Anzor G GvritishviliJoyce Tombran-Tink
Jun 21, 2012·Molecular Medicine·Sangeeta S ChavanKevin J Tracey
Dec 12, 2012·Biomarkers in Medicine·Nicola Santoro, Ram Weiss
Feb 11, 2011·Oxidative Medicine and Cellular Longevity·Ying YangJames R Sowers
May 15, 2007·Cell and Tissue Research·Ana Luisa PinaSabine Kloth
May 7, 2013·Expert Opinion on Drug Discovery·Susan E CrawordOlga V Volpert
May 28, 2010·Cancer Investigation·Dick WågsäterJan Dimberg
Dec 25, 2015·Molecular and Cellular Endocrinology·Revathy CarnagarinCrispin R Dass
Jan 26, 2016·Metabolic Syndrome and Related Disorders·Harry Robberecht, Nina Hermans
Aug 16, 2011·Biochimica Et Biophysica Acta·Khalid AlwailiJacques Genest
Aug 22, 2008·Diabetes Research and Clinical Practice·Alicia JenkinsJian-Xing Ma
May 6, 2008·Diabetes Research and Clinical Practice·Naoto KatakamiMunehide Matsuhisa
Dec 26, 2006·Regulatory Peptides·Alicja Wiercinska-DrapaloDanuta Prokopowicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.